152 related articles for article (PubMed ID: 29154408)
1. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
[TBL] [Abstract][Full Text] [Related]
2. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
3. Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.
Schmutz C; Cartwright A; Williams H; Haworth O; Williams JH; Filer A; Salmon M; Buckley CD; Middleton J
Arthritis Res Ther; 2010; 12(4):R161. PubMed ID: 20738854
[TBL] [Abstract][Full Text] [Related]
4. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
5. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
6. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
7. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
[TBL] [Abstract][Full Text] [Related]
8. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
Yokoyama W; Kohsaka H; Kaneko K; Walters M; Takayasu A; Fukuda S; Miyabe C; Miyabe Y; Love PE; Nakamoto N; Kanai T; Watanabe-Imai K; Charvat TT; Penfold ME; Jaen J; Schall TJ; Harigai M; Miyasaka N; Nanki T
Arthritis Res Ther; 2014 Sep; 16(5):445. PubMed ID: 25248373
[TBL] [Abstract][Full Text] [Related]
10. Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions.
Spinnen J; Fröhlich K; Sinner N; Stolk M; Ringe J; Shopperly L; Sittinger M; Dehne T; Seifert M
J Nanobiotechnology; 2021 Mar; 19(1):83. PubMed ID: 33766057
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
Ullah M; Eucker J; Sittinger M; Ringe J
Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
[TBL] [Abstract][Full Text] [Related]
12. CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts.
Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Ahmad I; Tetali C; Sweiss N; Amin MA; Zomorrodi RK; Shahrara S
Eur J Immunol; 2021 Apr; 51(4):903-914. PubMed ID: 33347617
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure.
Liu M; Wang P; Zhao M; Liu DY
PLoS One; 2016; 11(11):e0166165. PubMed ID: 27832135
[TBL] [Abstract][Full Text] [Related]
14. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
[TBL] [Abstract][Full Text] [Related]
15. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
[TBL] [Abstract][Full Text] [Related]
16. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
17. CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.
López-Pacheco C; Soldevila G; Du Pont G; Hernández-Pando R; García-Zepeda EA
Mediators Inflamm; 2016; 2016():3635809. PubMed ID: 27795621
[TBL] [Abstract][Full Text] [Related]
18. Anti-CCL25 antibody prolongs skin allograft survival by blocking CCR9 expression and impairing splenic T-cell function.
Li J; Xiong T; Xiao R; Xiong A; Chen J; Altaf E; Zheng Y; Zhu G; He Y; Tan J
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):237-44. PubMed ID: 23456208
[TBL] [Abstract][Full Text] [Related]
19. CCR9 and CCL25: A review of their roles in tumor promotion.
Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CCR9 expression and thymus-expressed chemokine responsiveness of the murine thymus, spleen and mesenteric lymph node.
Lee HS; Kim HR; Lee EH; Jang MH; Kim SB; Park JW; Seoh JY; Jung YJ
Immunobiology; 2012 Apr; 217(4):402-11. PubMed ID: 22196895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
